Theorem Clinical Research

Archives

Choose a date range

From To

Choose one or more categories

Categories:



Show only original CenterWatch stories

 


KCR relocates head office to Berlin to bring business closer to clients

Wednesday, March 11, 2015 12:27 PM

KCR, a CRO operating in 19 European countries and the U.S., is relocating its head office from Warsaw, Poland, to Berlin, Germany. The new location will better serve its own customers and support the company’s expanding services and operations.

More... »

Quest Diagnostics

AstraZeneca to collaborate with Singapore research organizations on heart failure

Wednesday, March 11, 2015 12:26 PM

AstraZeneca has formed a two-year collaboration with Singapore organizations including the Agency for Science, Technology and Research (A*STAR), National University Heart Center, Singapore (NUHCS) and National University of Singapore to support research into new therapies for heart failure.

More... »


Seven Bridges Genomics U.K. to receive $2.9M to launch Graph Genome

Wednesday, March 11, 2015 12:24 PM

Seven Bridges Genomics U.K. will receive approximately $2.9 million to complete and launch the world’s first functional Graph Genome reference and suite of related tools, thanks to a Small Business Research Initiative grant from the U.K. Department of Health and Genomics England.

More... »

Illumina, Merck Serono collaborate to expand companion diagnostics for oncology

Wednesday, March 11, 2015 12:22 PM

Illumina, a San Diego-based provider of sequencing and array-based technologies, has formed a collaboration with Merck Serono, the biopharmaceuticals business of Merck, based in Darmstadt, Germany, to develop a universal next-generation sequencing (NGS)-based oncology diagnostic.

More... »

MedImmune, Joslin Diabetes Center collaborate on metabolic disease research

Wednesday, March 11, 2015 12:21 PM

MedImmune, the global biologics R&D arm of AstraZeneca, and Joslin Diabetes Center, a diabetes research and clinical care organization based in Boston, Mass., have inked a three-year research collaboration to develop new medicines for the treatment of diabetes, obesity and related metabolic disorders.

More... »

Biomedical Systems launches next generation eCOA technology

Wednesday, March 11, 2015 12:20 PM

Biomedical Systems, a global provider of centralized diagnostic services headquartered in St. Louis, Mo., launches its second generation clinical outcome assessment software offering three platforms to collect patient data. This new electronic patient recorded outcome (ePRO) technology improves patient and investigator user experience, improves patient compliance and expedites study setup by simplifying site tasks and reducing errors.

More... »

CROS NT extends Datatrak Connect partnership

Monday, March 9, 2015 12:24 PM

CROS NT, an international CRO based in Chapel Hill, N.C., is extending its partnership with Datatrak, a worldwide technology and services company, as part of its life science technology portfolio. The partnership allows CROS NT to provide Datatrak's Unified eClinical platform, which includes Electronic Data Capture (EDC), Clinical Trial Management System (CTMS), randomization and clinical trial supply management (RTSM), as well as a web-based patient diary (ePRO).

More... »

Epic Sciences, Prostate Cancer Clinical Trials Consortium collaborate

Monday, March 9, 2015 12:22 PM

Epic Sciences, a San Diego, Calif.-based developer of novel diagnostics to personalize and advance the treatment and management of cancer, and the Prostate Cancer Clinical Trials Consortium (PCCTC), a consortium for phase I/II and phase II clinical trials in prostate cancer, will collaborate to apply Epic's circulating tumor cell (CTC) technology in multiple investigator-initiated clinical trials to advance the development of new prostate cancer treatments.

More... »

Targacept, Catalyst Biosciences ink merger

Monday, March 9, 2015 12:20 PM

Targacept, a biopharma company based in Winston-Salem, N.C., and Catalyst Biosciences, a privately held biopharma company based in South San Francisco, Calif., have agreed to merge. The combined entity, to be named Catalyst Biosciences, is expected to create a financially strong company to harness the catalytic power of engineered human proteases to develop next-generation biopharmaceuticals with improved efficacy and therapeutic index to treat major diseases.

More... »

Biomarkers Across Neurodegenerative Diseases launches $2M funding cycle

Monday, March 9, 2015 12:15 PM

Biomarkers Across Neurodegenerative Diseases (BAND) is launching a new funding cycle of nearly $2 million for projects investigating the overlap in the biology and clinical symptoms of Alzheimer's, Parkinson's, frontotemporal dementia (FTD) and other brain-deteriorating diseases.

More... »

AiCure
CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs